KROS
Keros Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$11.02
+0.03 ▲ +0.27%
🌙 3월 13일 4:20 PM ET (한국 3/14 05:20)
$11.02
+0.00 +0.00%
| Index | RUT | P/E | 6.05 | EPS (ttm) | 1.82 | Insider Own | 5.4% | Shs Outstand | 0.02B | Perf Week | -2.48% |
| Market Cap | 0.22B | Forward P/E | - | EPS next Y | -17.61% | Insider Trans | -90.54% | Shs Float | 0.02B | Perf Month | -35.33% |
| Enterprise Value | -0.05B | PEG | - | EPS next Q | -1.03 | Inst Own | 98.47% | Short Float | 10.89% | Perf Quarter | -49.54% |
| Income | 0.09B | P/S | 0.89 | EPS this Y | -312.66% | Inst Trans | -52.19% | Short Ratio | 4.94 | Perf Half Y | -30.08% |
| Sales | 0.24B | P/B | 0.71 | EPS next 5Y | - | ROA | 18.15% | Short Interest | 2.03M | Perf YTD | -45.87% |
| Book/sh | 15.51 | P/C | 0.76 | EPS past 3/5Y | - | ROE | 19.9% | 52W High | -51.13% ($22.55) | Perf Year | -3.92% |
| Cash/sh | 14.58 | P/FCF | 2.05 | Sales past 3/5Y | - | ROIC | 27.4% | 52W Low | 20.83% ($9.12) | Perf 3Y | -75.47% |
| Dividend Est. | - | EV/EBITDA | -0.77 | EPS Y/Y TTM | 137.16% | Gross Margin | 99.38% | Volatility(W/M) | 6.33% 5.14% | Perf 5Y | -83.09% |
| Dividend TTM | - | EV/Sales | -0.22 | Sales Y/Y TTM | 6774.96% | Oper. Margin | 27.72% | ATR (14) | 0.76 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 15.45 | EPS Q/Q | 24.4% | Profit Margin | 35.65% | RSI (14) | 17.98 | Recom | 1.89 |
| Dividend Gr. 3/5Y | - | Current Ratio | 15.45 | Sales Q/Q | -87.34% | SMA20 | -20.72% ($13.9) | Beta | 0.97 | Target Price | $22.57 |
| Payout | - | Debt/Eq | 0.06 | Earnings | 3000000 | SMA50 | -33.61% ($16.6) | Rel Volume | 1.26 | Prev Close | $10.99 |
| Employees | 78 | LT Debt/Eq | 0.05 | EPS/Sales Surpr. | -23.37% -89.5% | SMA200 | -31.12% ($16) | Avg Volume(3M) | 0.41M | Price | $11.02 |
| IPO | 2020/4/8 | Option/Short | Yes/Yes | Trades | 6969 | Volume | 516,561 | Change | 0.27% |
뉴스 로딩 중...